MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C

Cirrhosis likely shares common pathophysiological pathways despite arising from a variety of liver diseases. A recent GWAS identified rs641738, a polymorphism in the MBOAT7 locus, as being associated with the development of alcoholic cirrhosis. Here we explore the role of this variant on liver infla...

Descripción completa

Detalles Bibliográficos
Autores: Thabet, K, Asimakopoulos, A, Shojaei, M, Romero Gómez, Manuel, Mangia, Alessandra, Irving, WL, Berg, T, Rojas, Ángela, Eslam, Mohammed, International Liver Disease Genetics Consortium, Gallego Durán, Rocío
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2016
País:España
Institución:Universidad de Sevilla (US)
Repositorio:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:dnet:idus________::e92654c3b1f2c52a3e7b8153aefbbdfe
Acceso en línea:https://hdl.handle.net/11441/183977
https://doi.org/10.1038/ncomms12757
Access Level:acceso abierto
Palabra clave:Insulin-resistance genotype
Disease
Immunopathogenes
Isacyltransferases
Identification
Steatosis
Impacts
Variant
Models
Descripción
Sumario:Cirrhosis likely shares common pathophysiological pathways despite arising from a variety of liver diseases. A recent GWAS identified rs641738, a polymorphism in the MBOAT7 locus, as being associated with the development of alcoholic cirrhosis. Here we explore the role of this variant on liver inflammation and fibrosis in two cohorts of patients with chronic hepatitis C. In 2,051 patients, rs641738 associated with severe hepatic inflammation and increased risk of fibrosis, as well as fast fibrosis progression. At functional level, rs641738 associated with MBOAT7 transcript and protein levels in liver and blood, and with serum inflammatory, oxidative stress and macrophage activation markers. MBOAT7 was expressed in immune cell subsets, implying a role in hepatic inflammation. We conclude that the MBOAT7 rs641738 polymorphism is a novel risk variant for liver inflammation in hepatitis C, and thereby for liver fibrosis.